News

Podcast: Dr Phil Jones shares his career journey in discovery

22 August 2019

In a recent podcast, Bioscent’s Chief Scientific Officer, Dr Phil Jones, talks about his career and what he has learned...

Dr Phil Jones supports early stage projects at the University of Glasgow

20 August 2019

BioAscent’s Chief Scientific Officer, Dr Phil Jones has been working with the Translational Research Initiative within t...

Graham Simpson MSP visits BioAscent

05 July 2019

BioAscent welcomed Graham Simpson, MSP for Central Scotland, on site this week to showcase its biology, chemistry and st...

BIA Report – Life sciences: catalysing investment and growth (2)

05 July 2019

A recent report from the UK Bioindustry Association (BIA), sets out how the UK life sciences sector is driving investmen...

BioAscent records successful first year as fully integrated discovery services CRO

20 June 2019

BioAscent Discovery Limited has announced a three-fold increase in revenues during 2018, with projections on-track for a...

BioAscent chosen as partner for European Lead Factory’s ESCulab project

13 May 2019

The European Lead Factory, Europe’s largest collaborative drug discovery platform, has selected BioAscent as a partner i...

BioAscent announced as CRO partner for Medicines Discovery Catapult Virtual R&D group

03 May 2019

BioAscent has been selected as one of the world-class CRO partners tasked with delivering support to the UK Medicines Di...

BioAscent collaborates with Heriot-Watt University on heart stent inflammation drug discovery program

23 April 2019

Scientists at Heriot-Watt University and the European Screening Centre (now part of BioAscent) have collaborated to find...

Maximising efficient compound management

02 April 2019

BioAscent COO and Co-founder, Sylviane Boucharens, and Chief Commercial Officer, Mike Piper, were recently interviewed f...

BioAscent’s COO, Sylviane Boucharens named in top 50 Movers and Shakers in BioBusiness

06 November 2018

BioAscent’s COO, Sylviane Boucharens, has been included in the BioBeat 2018 list of 50 Movers and Shakers in BioBusiness...

About Us

Integrated Drug Discovery

Compound Management

Resources

News & Events

Careers

Podcast: Dr Phil Jones shares his career journey in discovery

Dr Phil Jones supports early stage projects at the University of Glasgow

Graham Simpson MSP visits BioAscent

BIA Report – Life sciences: catalysing investment and growth (2)

BioAscent records successful first year as fully integrated discovery services CRO

BioAscent chosen as partner for European Lead Factory’s ESCulab project

BioAscent announced as CRO partner for Medicines Discovery Catapult Virtual R&D group

BioAscent collaborates with Heriot-Watt University on heart stent inflammation drug discovery program

Maximising efficient compound management

BioAscent’s COO, Sylviane Boucharens named in top 50 Movers and Shakers in BioBusiness

Integrated Drug Discovery

Compound Management

Medicinal Chemistry

In Silico Discovery

Discovery Biology

Get in Touch

Our Site

About Us

Integrated Drug Discovery

Compound Management

Resources

News & Events

Careers

News

Podcast: Dr Phil Jones shares his career journey in discovery

Dr Phil Jones supports early stage projects at the University of Glasgow

Graham Simpson MSP visits BioAscent

BIA Report – Life sciences: catalysing investment and growth (2)

BioAscent records successful first year as fully integrated discovery services CRO

BioAscent chosen as partner for European Lead Factory’s ESCulab project

BioAscent announced as CRO partner for Medicines Discovery Catapult Virtual R&D group

BioAscent collaborates with Heriot-Watt University on heart stent inflammation drug discovery program

Maximising efficient compound management

BioAscent’s COO, Sylviane Boucharens named in top 50 Movers and Shakers in BioBusiness

Integrated Drug Discovery

Compound Management

Medicinal Chemistry

In Silico Discovery

Discovery Biology

Get in Touch